REFERENCES
- El-Beshlawy A, Seoud H, Ibrahim A, Apoptosis in thalassemia major reduced by a Butyrate Derivative. Acta Haematol. 2005;114:155–159.
- Vasileiadis P, Roditis S, Dimopoulos V, Impaired oxygen kinetics in beta-thalassaemia major subjects. Acta physiol. 2009;196:357–363.
- Vasileios T, Georgia L-A. Serum carnitine level in subjects with homozygous beta thalassemia: a possible new role for carnitine? Eur J Pediatr. 2005;164:131–134.
- Amal El-B, Ramzi El A, Mansour Abd El-S, Effect of L-carnitine on the physical fitness of thalassemic patients. Ann Hematol. 2007;86:31–34.
- Rashid M, Abhay J, Amish U, L-carnitine in beta thalassemia. Indian Pediatr. 2010; 47(2):165–167.
- Fereidon Mojtahedzadeh MD, Mehrnoush Kosaryan MD, Mohammad-Reza Mhdavi MD, Jafar Akbari MD. The effect of folic acid supplementation in beta-thalassemia major: a randomized placebo- controlled clinical trial. Arch Iranian Med. 2006;9(3):266–268.
- Prieto JA, Andrade F, Aldámiz-Echevarría L, Sanjurjo P. Determination of free and total carnitine in plasma by an enzymatic reaction and spectrophotometric quantitation spectrophotometric determination of carnitine. Clin Biochem. 2006;39(10):1022–1027.
- Toptas B, Baykal A, Yesilipek A, L-carnitine deficiency and red blood cell mechanical impairment in β thalassemia major. Clin Hematol Microcirulation. 2006;35:349–357.
- Engel AG, Angelini C. Carnitine deficiency of human skeletal muscles with associated lipid storage myopathy: a new syndrome. Science. 1973;179:899–902.
- Karpati G, Carpenter S, Engel AG, The syndrome of systemic carnitine deficiency: clinical, morphologic, biochemical and pathophysiologic features. Neurology. 1975;25:16–24.
- Ferrari R, Cargoni A, de Giuli F, Propionyi L_carnitine improves skeletal muscles metabolism and exercise capacity of patients with congestive heart failure. Circulation. 1993;88:1414.
- Amal El-B, Lamis R, Alia Abdel F, Improvement of cardic function in thalassemia major treated with L-carnitine. Acta Hematology. 2004;111:143–148.
- Palinicir L, Ronaca F, Malengo S, Bericlli A. Protection of β_thalassemia erythrocytes from oxidative stress by propionti carnitine. Int J Tiss React. 1994;16:121–129.
- Mehran K, Faranak M, Farzane B, Effect of combination therapy of hydroxyurea with l-carnitine and magnesium chloride on hematologic parameters and cardiac function of patients with β-thalassemia Intermedia. Eur J Haematol. 2009;84:52–58.
- Gallerani M, Cicognani I, Ballardini P, Analysis of folate and vitamin B12 in beta thalassemia minor. M. Riv Eur Sci Med Farmacol. 1990;12(4–5):247–250.
- Silva AE, Varella-Garcia M. Plasma folate and vitamin B12 levels in beta-thalassemia heterozygotes. Braz J Med Biol Res. 1989;22(10):1225–1228.
- Castaldi G, Bagni B, Trotta F, Folic acid deficiency in beta-thalassaemia heterozygotes. Scand J Haematol. 1983;30(2):125–129.